Seminars in Oncology
Volume 31, Issue 6 , Pages 744-754 , December 2004

Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity

  • Maura L. Gillison

      Affiliations

    • Department of Medical Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins School of Medicine, and Departments of Epidemiology and Molecular Microbiology and Immunology of the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
    • Corresponding Author InformationAddress reprint requests to Maura L. Gillison, MD, PhD, Bunting-Blaustein Cancer Research Building, 1650 Orleans St, Baltimore, MD 21231

References 

  1. Syrjanen K , Syrjanen S , Lamberg M , et al.   Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis . Int J Oral Surg . 1983;12:418–424
  2. Loning T , Ikenberg H , Becker J , et al.   Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA . J Invest Dermatol . 1985;84:417–420
  3. Franceschi S , Munoz N , Bosch XF , et al.   Human papillomavirus and cancers of the upper aerodigestive tract (A review of epidemiological and experimental evidence) . Cancer Epidemiol Biomarkers Prev . 1996;5:567–575
  4. Niedobitek G , Pitteroff S , Herbst H , et al.   Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil . J Clin Pathol . 1990;43:918–921
  5. Snijders PJ , Cromme FV , van den Brule AJ , et al.   Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology . Int J Cancer . 1992;51:845–850
  6. Schwartz SM , Daling JR , Doody DR , et al.   Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection . J Natl Cancer Inst . 1998;90:1626–1636
  7. Gillison ML , Koch WM , Capone RB , et al.   Evidence for a causal association between human papillomavirus and a subset of head and neck cancers . J Natl Cancer Inst . 2000;92:709–720
  8. Andl T , Kahn T , Pfuhl A , et al.   Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control . Cancer Res . 1998;58:5–13
  9. Wiest T , Schwarz E , Enders C , et al.   Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control . Oncogene . 2002;21:1510–1517
  10. van Houten VM , Snijders PJ , van den Brekel MW , et al.   Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas . Int J Cancer . 2001;93:232–235
  11. Hafkamp HC , Speel EJ , Haesevoets A , et al.   A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5–8 . Int J Cancer . 2003;107:394–400
  12. Mork J , Lie AK , Glattre E , et al.   Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck . N Engl J Med . 2001;344:1125–1131
  13. Frisch M , Hjalgrim H , Jaeger AB , et al.   Changing patterns of tonsillar squamous cell carcinoma in the United States . Cancer Causes Control . 2000;11:489–495
  14. Gagnon JH , Simon W . The sexual scripting of oral genital contacts . Arch Sex Behav . 1987;16:1–25
  15. Evans BA , McCormack SM , Kell PD , et al.   Trends in female sexual behaviour and sexually transmitted diseases in London, 1982–1992 . Genitourin Med . 1995;71:286–290
  16. Munoz N , Bosch FX , de Sanjose S , et al.   Epidemiologic classification of human papillomavirus types associated with cervical cancer . N Engl J Med . 2003;348:518–527
  17. McDougall JK . Immortalization and transformation of human cells by human papillomavirus . Curr Top Microbiol Immunol . 1994;186:101–119
  18. Munger K , Howley PM . Human papillomavirus immortalization and transformation functions . Virus Res . 2002;89:213–228
  19. Nasseri M , Gage JR , Lorincz A , et al.   Human papillomavirus type 16 immortalized cervical keratinocytes contain transcripts encoding E6, E7, and E2 initiated at the P97 promoter and express high levels of E7 . Virology . 1991;184:131–140
  20. Schwarz E , Freese UK , Gissmann L , et al.   Structure and transcription of human papillomavirus sequences in cervical carcinoma cells . Nature . 1985;314:111–114
  21. Howley PM . Role of the human papillomaviruses in human cancer . Cancer Res . 1991;51(suppl 18):5019s–5022s
  22. Crook T , Morgenstern JP , Crawford L , et al.   Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras . EMBO J . 1989;8:513–519
  23. Balz V , Scheckenbach K , Gotte K , et al.   Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2–11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens . Cancer Res . 2003;63:1188–1191
  24. Pintos J , Franco EL , Black MJ , et al.   Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tract . Cancer . 1999;85:1903–1909
  25. Snijders PJ , Scholes AG , Hart CA , et al.   Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck . Int J Cancer . 1996;66:464–469
  26. Brandwein M , Zeitlin J , Nuovo GJ , et al.   HPV detection using “hot start” polymerase chain reaction in patients with oral cancer (A clinicopathological study of 64 patients) . Mod Pathol . 1994;7:720–727
  27. Paz IB , Cook N , Odom-Maryon T , et al.   Human papillomavirus (HPV) in head and neck cancer (An association of HPV 16 with squamous cell carcinoma of Waldeyer’s tonsillar ring) . Cancer . 1997;79:595–604
  28. Fouret P , Monceaux G , Temam S , et al.   Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers . Arch Otolaryngol Head Neck Surg . 1997;123:513–516
  29. Ritchie JM , Smith EM , Summersgill KF , et al.   Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx . Int J Cancer . 2003;104:336–344
  30. Haraf DJ , Nodzenski E , Brachman D , et al.   Human papilloma virus and p53 in head and neck cancer (Clinical correlates and survival) . Clin Cancer Res . 1996;2:755–762
  31. Wilczynski SP , Lin BT , Xie Y , et al.   Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma . Am J Pathol . 1998;152:145–156
  32. Gillison M , Koch W , Capone R , et al.   Evidence for a causal association between human papillomavirus and a subset of head and neck cancers . J Natl Cancer Inst . 2000;92:709–720
  33. Mellin H , Friesland S , Lewensohn R , et al.   Human papillomavirus (HPV) DNA in tonsillar cancer (Clinical correlates, risk of relapse, and survival) . Int J Cancer . 2000;89:300–304
  34. Klussmann JP , Gultekin E , Weissenborn SJ , et al.   Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus . Am J Pathol . 2003;162:747–753
  35. Strome SE , Savva A , Brissett AE , et al.   Squamous cell carcinoma of the tonsils (A molecular analysis of HPV associations) . Clin Cancer Res . 2002;8:1093–1100
  36. Herrero R , Catellsague X , Munoz N , et al.  The International Agency for Research on Cancer Multicenter Study   Human papillomavirus and oral cancer . J Natl Cancer Inst . 2003;95:1772–1783
  37. Mellin H , Dahlgren L , Munck-Wikland E , et al.   Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer . Int J Cancer . 2002;102:152–158
  38. Klussmann JP , Weissenborn SJ , Wieland U , et al.   Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas . Cancer . 2001;92:2875–2884
  39. Klussmann JP , Weissenborn SJ , Wieland U , et al.   Human papillomavirus-positive tonsillar carcinomas (A different tumor entity?) . Med Microbiol Immunol (Berl) . 2003;192:129–132
  40. Ha PK , Pai SI , Westra WH , et al.   Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity . Clin Cancer Res . 2002;8:1203–1209
  41. Steenbergen RD , Hermsen MA , Walboomers JM , et al.   Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line . Cancer Res . 1995;55:5465–5471
  42. Ke LD , Adler-Storthz K , Mitchell MF , et al.   Expression of human papillomavirus E7 mRNA in human oral and cervical neoplasia and cell lines . Oral Oncol . 1999;35:415–420
  43. Zumbach K , Hoffmann M , Kahn T , et al.   Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma . Int J Cancer . 2000;85:815–818
  44. Lindel K , Beer KT , Laissue J , et al.   Human papillomavirus positive squamous cell carcinoma of the oropharynx (A radiosensitive subgroup of head and neck carcinoma) . Cancer . 2001;92:805–813
  45. Koskinen WJ , Chen RW , Leivo I , et al.   Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck . Int J Cancer . 2003;107:401–406
  46. Brachman DG , Graves D , Vokes E , et al.   Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer . Cancer Res . 1992;52:4832–4836
  47. Chiba I , Shindoh M , Yasuda M , et al.   Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity . Oncogene . 1996;12:1663–1668
  48. Snijders PJ , Steenbergen RD , Top B , et al.   Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus . J Gen Virol . 1994;75:2769–2775
  49. Sisk EA , Soltys SG , Zhu S , et al.   Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma . Head Neck . 2002;24:841–849
  50. Magal SS , Jackman A , Pei XF , et al.   Induction of apoptosis in human keratinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins . Int J Cancer . 1998;75:96–104
  51. Song S , Gulliver GA , Lambert PF . Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways . Proc Natl Acad Sci U S A . 1998;95:2290–2295
  52. Hemminki K , Jiang Y , Dong C . Second primary cancers after anogenital, skin, oral, esophageal and rectal cancers (Etiological links?) . Int J Cancer . 2001;93:294–298
  53. Dellambra E , Golisano O , Bondanza S , et al.   Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes . J Cell Biol . 2000;149:1117–1130
  54. Gasco M , Bell AK , Heath V , et al.   Epigenetic inactivation of 14-3-3 sigma in oral carcinoma (Association with p16(INK4a) silencing and human papillomavirus negativity) . Cancer Res . 2002;62:2072–2076
  55. Dong SM , Sun DI , Benoit NE , et al.   Epigenetic inactivation of RASSF1A in head and neck cancer . Clin Cancer Res . 2003;9:3635–3640
  56. Li Y , Nichols MA , Shay JW , et al.   Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb . Cancer Res . 1994;54:6078–6082
  57. Olshan AF , Weissler MC , Pei H , et al.   Alterations of the p16 gene in head and neck cancer (Frequency and association with p53, PRAD-1 and HPV) . Oncogene . 1997;14:811–818
  58. Shintani S , Nakahara Y , Mihara M , et al.   Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas . Oral Oncol . 2001;37:498–504
  59. Nakao Y , Yang X , Yokoyama M , et al.   Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation . Br J Cancer . 1997;75:1410–1416
  60. Klaes R , Friedrich T , Spitkovsky D , et al.   Overexpression of p16 (INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri . Int J Cancer . 2001;92:276–284
  61. Begum S , Gillison ML , Ansari-Lari MA , et al.   Detection of human papillomavirus in cervical lymph nodes (A highly efffective strategy for localizing site of tumor origin in patients with metastatic squamous cell carcinoma of the head and neck) . Clin Cancer Res . 2003;9:6469–6475
  62. von Gaudecker B . Development and functional anatomy of the human tonsilla palatina . Acta Otolaryngol . 1988;454(suppl):28–32
  63. Clark MA , Wilson C , Sama A , et al.   Differential cytokeratin and glycoconjugate expression by the surface and crypt epithelia of human palatine tonsils . Histochem Cell Biol . 2000;114:311–321
  64. Kang MK , Park NH . Conversion of normal to malignant phenotype (Telomere shortening, telomerase activation, and genomic instability during immortalization of human oral keratinocytes) . Crit Rev Oral Biol Med . 2001;12:38–54
  65. Park NH , Min BM , Li SL , et al.   Immortalization of normal human oral keratinocytes with type 16 human papillomavirus . Carcinogenesis . 1991;12:1627–1631
  66. Li SL , Kim MS , Cherrick HM , et al.   Low p53 level in immortal, non-tumorigenic oral keratinocytes harboring HPV-16 DNA . Eur J Cancer B Oral Oncol . 1992;28B:129–134
  67. Liu X , Han S , Baluda MA , et al.   HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes . Oncogene . 1997;14:2347–2353
  68. Rey O , Lee S , Park NH . Impaired nucleotide excision repair in UV-irradiated human oral keratinocytes immortalized with type 16 human papillomavirus genome . Oncogene . 1999;18:6997–7001
  69. Guo W , Kang MK , Kim HJ , et al.   Immortalization of human oral keratinocytes is associated with elevation of telomerase activity and shortening of telomere length . Oncol Rep . 1998;5:799–804
  70. Itakura M , Mori S , Park NH , et al.   Both HPV and carcinogen contribute to the development of resistance to apoptosis during oral carcinogenesis . Int J Oncol . 2000;16:591–597
  71. Kim MS , Shin KH , Baek JH , et al.   HPV-16, tobacco-specific N-nitrosamine, and N-methyl-N′-nitro-N-nitrosoguanidine in oral carcinogenesis . Cancer Res . 1993;53:4811–4816
  72. Li SL , Kim MS , Cherrick HM , et al.   Sequential combined tumorigenic effect of HPV-16 and chemical carcinogens . Carcinogenesis . 1992;13:1981–1987
  73. Ringstrom E , Peters E , Hasegawa M , et al.   Human papillomavirus type 16 and squamous cell carcinoma of the head and neck . Clin Cancer Res . 2002;8:3187–3192
  74. Brandsma JL , Abramson AL . Association of papillomavirus with cancers of the head and neck . Arch Otolaryngol Head Neck Surg . 1989;115:621–625
  75. Zoltan S , Szabolcs O , Miklos K . Indications for molecular detection of human papillomavirus (HPV) . Magy Onkol . 2002;46:235–237
  76. Poetsch M , Lorenz G , Bankau A , et al.   Basaloid in contrast to nonbasaloid head and neck squamous cell carcinomas display aberrations especially in cell cycle control genes . Head Neck . 2003;25:904–910
  77. El-Mofty SK , Lu DW . Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients (A distinct clinicopathologic and molecular disease entity) . Am J Surg Pathol . 2003;27:1463–1470
  78. Li W , Thompson CH , O’Brien CJ , et al.   Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil . Int J Cancer . 2003;106:553–558
  79. Schwartz SR , Yueh B , McDougall JK , et al.   Human papillomavirus infection and survival in oral squamous cell cancer (A population-based study) . Otolaryngol Head Neck Surg . 2001;125:1–9
  80. Portugal LG , Goldenberg JD , Wenig BL , et al.   Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma . Arch Otolaryngol Head Neck Surg . 1997;123:1230–1234
  81. Butz K , Whitaker N , Denk C , et al.   Induction of the p53-target gene GADD45 in HPV-positive cancer cells . Oncogene . 1999;18:2381–2386
  82. Huang H , Li CY , Little JB . Abrogation of P53 function by transfection of HPV16 E6 gene does not enhance resistance of human tumour cells to ionizing radiation . Int J Radiat Biol . 1996;70:151–160
  83. DeWeese TL , Walsh JC , Dillehay LE , et al.   Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation . Int J Radiat Oncol Biol Phys . 1997;37:145–154
  84. Liu DW , Tsao YP , Kung JT , et al.   Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer . J Virol . 2000;74:2888–2894
  85. Fornatora M , Jones AC , Kerpel S , et al.   Human papillomavirus-associated oral epithelial dysplasia (koilocytic dysplasia) (An entity of unknown biologic potential) . Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 1996;82:47–56
  86. Miller CS , White DK . Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma (A retrospective review of the literature) . Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 1996;82:57–68
  87. Syrjanen SM , Syrjanen KJ , Happonen RP . Human papillomavirus (HPV) DNA sequences in oral precancerous lesions and squamous cell carcinoma demonstrated by in situ hybridization . J Oral Pathol . 1988;17:273–278
  88. Wen S , Tsuji T , Li X , et al.   Detection and analysis of human papillomavirus 16 and 18 homologous DNA sequences in oral lesions . Anticancer Res . 1997;17:307–311
  89. Nielsen H , Norrild B , Vedtofte P , et al.   Human papillomavirus in oral premalignant lesions . Eur J Cancer B Oral Oncol . 1996;32B:264–270
  90. Shroyer KR , Greer RO . Detection of human papillomavirus DNA by in situ DNA hybridization and polymerase chain reaction in premalignant and malignant oral lesions . Oral Surg Oral Med Oral Pathol . 1991;71:708–713
  91. Elamin F , Steingrimsdottir H , Wanakulasuriya S , et al.   Prevalence of human papillomavirus infection in premalignant and malignant lesions of the oral cavity in U.K. subjects (A novel method of detection) . Oral Oncol . 1998;34:191–197
  92. D’Costa J , Saranath D , Dedhia P , et al.   Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India . Oral Oncol . 1998;34:413–420
  93. Fregonesi PA , Teresa DB , Duarte RA , et al.   p16(INK4A) Immunohistochemical overexpression in premalignant and malignant oral lesions infected with human papillomavirus . J Histochem Cytochem . 2003;51:1291–1297
  94. Kansky AA , Poljak M , Seme K , et al.   Human papillomavirus DNA in oral squamous cell carcinomas and normal oral mucosa . Acta Virol . 2003;47:11–16
  95. Giovannelli L , Campisi G , Lama A , et al.   Human papillomavirus DNA in oral mucosal lesions . J Infect Dis . 2002;185:833–836
  96. Bouda M , Gorgoulis VG , Kastrinakis NG , et al.   “High risk” HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa . Mod Pathol . 2000;13:644–653
  97. Pillai MR , Phanidhara A , Kesari AL , et al.   Cellular manifestations of human papillomavirus infection in the oral mucosa . J Surg Oncol . 1999;71:10–15
  98. Sand L , Jalouli J , Larsson PA , et al.   Human papilloma viruses in oral lesions . Anticancer Res . 2000;20:1183–1188
  99. Sugiyama M , Bhawal UK , Dohmen T , et al.   Detection of human papillomavirus-16 and HPV-18 DNA in normal, dysplastic, and malignant oral epithelium . Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 2003;95:594–600
  100. Kutler DI , Weesermann VB , Goberdhan A , et al.   Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas form Fanconi anemia patients . J Natl Cancer Inst . 2003;95:1718–1721
  101. Cruz IB , Snijders PJ , Steenbergen RD , et al.   Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas . Eur J Cancer B Oral Oncol . 1996;32B:55–62
  102. Coutlee F , Trottier AM , Ghattas G , et al.   Risk factors for oral human papillomavirus in adults infected and not infected with human immunodeficiency virus . Sex Transm Dis . 1997;24:23–31
  103. Summersgill KF , Smith EM , Levy BT , et al.   Human papillomavirus in the oral cavities of children and adolescents . Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 2001;91:62–69
  104. Kreimer A , Alberg AJ , Daniel R , et al.   Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus . J Infect Dis . 2004;189:686–698
  105. Silverberg MJ , Thorsen P , Lindeberg H , et al.   Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis . Obstet Gynecol . 2003;101:645–652
  106. Dahlstrom KR , Adler-Storthz K , Etzel CJ , et al.   Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers (A matched pair analysis) . Clin Cancer Res . 2003;9:2620–2626
  107. Smith EM , Hoffman HT , Summersgill KS , et al.   Human papillomavirus and risk of oral cancer . Laryngoscope . 1998;108:1098–1103
  108. Frisch M , Biggar RJ . Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas . Lancet . 1999;354:1442–1443
  109. Frisch M , Biggar RJ , Goedert JJ . Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome . J Natl Cancer Inst . 2000;92:1500–1510
  110. Lowy D , Gillison ML . New link between Fanconi anemia and human papillomavirus associated malignancies . J Natl Cancer Inst . 2003;95:1648–1650
  111. D’Andrea AD . The Fanconi road to cancer . Genes Dev . 2003;17:1933–1936
  112. Kutler DI , Singh B , Satagopan J , et al.   A 20-year perspective on the International Fanconi Anemia Registry (IFAR) . Blood . 2003;101:1249–1256
  113. Alter BP . Cancer in Fanconi anemia, 1927–2001 . Cancer . 2003;97:425–440
  114. Rosenberg PS , Greene MH , Alter BP . Cancer incidence in persons with Fanconi anemia . Blood . 2003;101:822–826
  115. Kutler DI , Auerbach AD , Satagopan J , et al.   High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia . Arch Otolaryngol Head Neck Surg . 2003;129:106–112
  116. Giampietro PF , Verlander PC , Davis JG , et al.   Diagnosis of Fanconi anemia in patients without congenital malformations (An International Fanconi Anemia Registry Study) . Am J Med Genet . 1997;68:58–61
  117. Auerbach AD . Fanconi anemia diagnosis and the diepoxybutane (DEB) test . Exp Hematol . 1993;21:731–733
  118. Lizard G , Demares-Poulet MJ , Roignot P , et al.   In situ hybridization detection of single-copy human papillomavirus on isolated cells, using a catalyzed signal amplification system (GenPoint) . Diagn Cytopathol . 2001;24:112–116
  119. Gravitt PE , Peyton C , Wheeler C , et al.   Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays . J Virol Methods . 2003;112:23–33
  120. Capone RB , Pai SI , Koch WM , et al.   Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma . Clin Cancer Res . 2000;6:4171–4175
  121. Veltman JA , Hopman AH , Bot FJ , et al.   Detection of chromosomal aberrations in cytologic brush specimens from head and neck squamous cell carcinoma . Cancer . 1997;81:309–314
  122. Zumbach K , Kisseljov F , Sacharova O , et al.   Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia . Int J Cancer . 2000;85:313–318
  123. Devaraj K , Gillison ML , Wu TC . Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma . Crit Rev Oral Biol Med . 2003;14:345–362
  124. Stanley MA . Progress in prophylactic and therapeutic vaccines for human papillomavirus infection . Expert Rev Vaccines . 2003;2:381–389
  125. Koutsky LA , Ault KA , Wheeler CM , et al.   A controlled trial of a human papillomavirus type 16 vaccine . N Engl J Med . 2002;347:1645–1651
  126. Chen CH , Wang TL , Hung CF , et al.   Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene . Cancer Res . 2000;60:1035–1042
  127. Ji H , Chang EY , Lin KY , et al.   Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein . Int J Cancer . 1998;78:41–45
  128. Frazer IM , Leonard JH , Schonrock J , et al.   HPV DNA in oropharyngeal squamous cell cancers (Comparison of results from four DNA detection methods) . Pathology . 1993;25:138–143

 Supported by grants from the NIADR (DE13121). M.L.G. is a Damon Runyon-Lilly Clinical Investigator supported (in part) by the Damon Runyon Cancer Research Foundation.

PII: S0093-7754(04)00408-7

doi: 10.1053/j.seminoncol.2004.09.011

Seminars in Oncology
Volume 31, Issue 6 , Pages 744-754 , December 2004

Article Tools

* Image Usage & Resolution